This study shows that eplerenone is indeed a more potent hair growth promoter than spironolactone. However, the study was only done using female frontotemporal hairs. If anything the effect should be more pronounced in Androgenetic Alopecia since aldosterone had no effect on the female HF, but has been
implicated in Androgenetic Alopecia pathology. I don't think eplerenone does much for Androgenetic Alopecia by itself, but it should significantly improve the results of AAs as an adjuvant therapy. There's no telling how much of a factor it's been in my regrowth. Theoretically, and now empirically, it's at least relevant.
View attachment 147449 View attachment 147450